Satsuma shares jump after board overhaul and £40m Bitcoin sale

Satsuma Technology's shares jumped as much as 28% after the company disclosed proposed board changes and the sale of 579 Bitcoin, raising net proceeds of about £40m as part of preparations to uplist to the FCA Official List and the LSE main market. The board moves would see Ranald McGregor-Smith replace Matt Lodge as chair (Lodge to remain on the board), with Clive Carver joining as senior independent director and audit chair; Darcy Taylor has resigned. The Bitcoin sale leaves Satsuma with 620 BTC and roughly £90m in cash against a £78m liability due Dec. 31 to ensure liquidity for convertible-note holders; the stock settled at 0.88p, up 7%, as the company seeks to shore up its balance sheet ahead of the uplisting.

Analysis

Satsuma Technology’s shares spiked as much as 28% intraday and settled up 7% at 0.88p after the company announced proposed board changes and the sale of 579 Bitcoin that generated net proceeds of about £40m; the moves are explicitly framed as preparations for an uplisting to the FCA Official List and the LSE main market. The board reshuffle would see Ranald McGregor-Smith named chair, Clive Carver joining as senior independent director and audit committee chair, Matt Lodge stepping down as chair but remaining on the board, and Darcy Taylor resigning as a non-executive director.

The company reports it now holds 620 Bitcoin and roughly £90m in cash while facing a £78m liability due on 31 December, and it sold BTC to ensure liquidity to repay holders of convertible loan notes who have not committed to conversion. CEO Henry K. Elder emphasized the sale provides accessible capital to execute the company’s long-term strategy and to position Satsuma as a regional Bitcoin business.

The announcement materially improves near-term liquidity but reduces the company’s Bitcoin exposure; the quoted market valuation of just under £5m versus reported cash of ~£90m implies the market is pricing significant liability, conversion or execution risk around the uplisting. Key near-term catalysts are resolution of the £78m convertible-note liability, the completion of the uplisting and formalization of the new board, any further asset sales, and potential dilution from note conversions.

Key Decisions for Investors

• Consider a tactical, event-driven position only if comfortable with execution risk given the large disparity between reported cash (~£90m) and the market valuation (~£5m),
• Monitor the outcome of the £78m convertible loan-note obligation due 31 December closely—non-conversion or further asset sales would materially alter equity value and should trigger reassessment or hedging of positions
• Watch progress on the uplisting and the effectiveness of the new board appointments as they are the primary catalysts to reduce the market discount; limit position size until those milestones are achieved and disclosures are confirmed